Search Menu
Photonics Media Photonics Marketplace Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

Hoya Corp. Invests Equity in LifeSpex

Facebook Twitter LinkedIn Email Comments
KIRKLAND, Wash., April 21 -- LifeSpex Inc. and Hoya Corp. report that Hoya Holdings Inc. has made a strategic equity investment in LifeSpex Corp. LifeSpex develops bio-photonics to provide point-of-care diagnostic systems for the detection of epithelial cancers. The company will use the investment proceeds to complete pivotal clinical trials for its Cerviscan product in the United States and Europe and to establish manufacturing capacity for early production shipments.
The Cerviscan system uses Evoked Tissue Fluorescence technology to enable physicians to directly assess and locate patients' cervical precancers and cancers in an office environment. LifeSpex Corp. has over 15 issued and blocking patents and patent applications in collaboration with the University of Texas at Austin.
Apr 1999
industrialNews & Features

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2021 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.